Bioventus (BVS) Gross Margin Growth (3y) (2023 - 2026)
Bioventus (BVS) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 113.00 |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | 395.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 395.00 |
| Mar 28, 2026 | 663.00 |
| Dec 31, 2025 | 994.00 |
| Sep 27, 2025 | 226.00 |
| Jun 28, 2025 | 26.00 |
| Mar 29, 2025 | 251.00 |
| Dec 31, 2024 | -48.00 |
| Sep 28, 2024 | -529.00 |
| Jun 29, 2024 | -96.00 |
| Mar 30, 2024 | -456.00 |
| Dec 31, 2023 | -1,079.00 |
| Sep 30, 2023 | -743.00 |
| Jul 1, 2023 | -453.00 |
| Apr 1, 2023 | -1,069.00 |